Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HLX07 +/- HLX10 in Advanced Metastatic Gastric Cancer
NCT05246982Phase 2Unknown
- Sponsor
- Henlius
- Start
- Mar 2022
- Primary completion
- Dec 2023
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of pimurutamab in gastric cancer (GC), gastroesophageal junction cancer, sponsored by Henlius. Status: unknown.
02
Drugs
pimurutamab
03
Conditions
gastric cancer (GC)gastroesophageal junction cancer
Beyond the preview
Go deeper on NCT05246982.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05246982.